---
$id: https://graph.org.ai/products/commodity/51161569
$type: Product
source: UNSPSC
code: "51161569"
title: "Montelukast sodium"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Montelukast sodium

**UNSPSC Code**: 51161569
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C35H35ClNO3S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U1O3J18SFL, chemically known as cyclopropaneacetic acid, 1-((((1r)-1-(3-((1e)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-, monosodium salt but more generally known as montelukast sodium, which bears US NIH Compound Identifier 5281041. European Medicines Agency schedules Montelukast sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03324MIG. Most nations, for tariff and trade purposes, schedule montelukast sodium under HS 29334990 and SITC 51575. As of Q4 2014, MONTELUKAST SODIUM remains US FDA's Preferred Term for this commodity. Montelukast sodium bears US NLM identifiers UMLS ID C0380447 and NCI Concept Code C47625. SMILES: CC(C)(C1CCCCC1CC[C@H](C2CCCC(C2)/C=C/C3CCC4CCC(CC4N3)CL)SCC5(CC5)CC(=O)[O-])O.[NA+].

